163 related articles for article (PubMed ID: 32454305)
1. Mortality in psoriatic arthritis: Risk, causes of death, predictors for death.
Elalouf O; Muntyanu A; Polachek A; Pereira D; Ye JY; Lee KA; Chandran V; Cook RJ; Gladman DD
Semin Arthritis Rheum; 2020 Aug; 50(4):571-575. PubMed ID: 32454305
[TBL] [Abstract][Full Text] [Related]
2. Improved survival in psoriatic arthritis with calendar time.
Ali Y; Tom BD; Schentag CT; Farewell VT; Gladman DD
Arthritis Rheum; 2007 Aug; 56(8):2708-14. PubMed ID: 17665458
[TBL] [Abstract][Full Text] [Related]
3. Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death.
Wong K; Gladman DD; Husted J; Long JA; Farewell VT
Arthritis Rheum; 1997 Oct; 40(10):1868-72. PubMed ID: 9336423
[TBL] [Abstract][Full Text] [Related]
4. The Association of Psoriatic Arthritis With All-cause Mortality and Leading Causes of Death in Psoriatic Arthritis.
Haddad A; Saliba W; Lavi I; Batheesh A; Kasem S; Gazitt T; Feldhamer I; Cohen AD; Zisman D
J Rheumatol; 2022 Feb; 49(2):165-170. PubMed ID: 34266988
[TBL] [Abstract][Full Text] [Related]
5. Trends in mortality and cause-specific mortality among patients with psoriasis and psoriatic arthritis in Ontario, Canada.
Colaco K; Widdifield J; Luo J; Rosen CF; Alhusayen R; Paterson JM; Campbell W; Tu K; Bernatsky S; Gladman DD; Eder L
J Am Acad Dermatol; 2021 May; 84(5):1302-1309. PubMed ID: 33096129
[TBL] [Abstract][Full Text] [Related]
6. Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register.
Fagerli KM; Kearsley-Fleet L; Mercer LK; Watson K; Packham J; Symmons DPM; Hyrich KL
Rheumatology (Oxford); 2019 Jan; 58(1):80-85. PubMed ID: 30137485
[TBL] [Abstract][Full Text] [Related]
7. Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study.
Ogdie A; Haynes K; Troxel AB; Love TJ; Hennessy S; Choi H; Gelfand JM
Ann Rheum Dis; 2014 Jan; 73(1):149-53. PubMed ID: 23264338
[TBL] [Abstract][Full Text] [Related]
8. Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis.
Ogdie A; Maliha S; Shin D; Love TJ; Baker J; Jiang Y; Choi H; Gelfand JM
Rheumatology (Oxford); 2017 Jun; 56(6):907-911. PubMed ID: 28158384
[TBL] [Abstract][Full Text] [Related]
9. Disease Activity and Increased Risk of Cardiovascular Death among Patients with Psoriatic Arthritis.
Juneblad K; Rantapää-Dahlqvist S; Alenius GM
J Rheumatol; 2016 Dec; 43(12):2155-2161. PubMed ID: 27909142
[TBL] [Abstract][Full Text] [Related]
10. Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden.
Tanash HA; Ekström M; Wagner P; Piitulainen E
Int J Chron Obstruct Pulmon Dis; 2016; 11():1663-9. PubMed ID: 27555756
[TBL] [Abstract][Full Text] [Related]
11. Mortality in psoriatic arthritis - a single-center study from the UK.
Buckley C; Cavill C; Taylor G; Kay H; Waldron N; Korendowych E; McHugh N
J Rheumatol; 2010 Oct; 37(10):2141-4. PubMed ID: 20682670
[TBL] [Abstract][Full Text] [Related]
12. Cause-Specific Mortality in Male US Veterans With Rheumatoid Arthritis.
England BR; Sayles H; Michaud K; Caplan L; Davis LA; Cannon GW; Sauer BC; Solow EB; Reimold AM; Kerr GS; Schwab P; Baker JF; Mikuls TR
Arthritis Care Res (Hoboken); 2016 Jan; 68(1):36-45. PubMed ID: 26097231
[TBL] [Abstract][Full Text] [Related]
13. Mortality in psoriatic arthritis patients, changes over time, and the impact of COVID-19: results from a multicenter Psoriatic Arthritis Registry (PsART-ID).
Erden A; Ayan G; Kilic L; Solmaz D; Bakirci S; Kimyon G; Günal EK; Dogru A; Bayindir O; Dalkilic E; Özisler C; Akar S; Cetin GY; Tarhan EF; Küçüksahin O; Omma A; Gonullu E; Yildiz F; Ersozlu ED; Cinar M; Tufan A; Pehlevan S; Esmen SE; Yilmaz S; Duruoz T; Kasifoglu T; Yazısız V; Aksu K; Aydin SZ; Kalyoncu U
Clin Rheumatol; 2023 Feb; 42(2):385-390. PubMed ID: 36637636
[TBL] [Abstract][Full Text] [Related]
14. Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.
Gladman DD; Farewell VT; Wong K; Husted J
Arthritis Rheum; 1998 Jun; 41(6):1103-10. PubMed ID: 9627021
[TBL] [Abstract][Full Text] [Related]
15. Causes that Contribute to the Excess Mortality Risk in Multiple Sclerosis: A Population-Based Study.
Kingwell E; Zhu F; Evans C; Duggan T; Oger J; Tremlett H
Neuroepidemiology; 2020; 54(2):131-139. PubMed ID: 31852000
[TBL] [Abstract][Full Text] [Related]
16. Mortality and causes of death in psoriatic arthritis.
Arumugam R; McHugh NJ
J Rheumatol Suppl; 2012 Jul; 89():32-5. PubMed ID: 22751588
[TBL] [Abstract][Full Text] [Related]
17. Malignancy in psoriatic disease: Results from prospective longitudinal cohorts.
Polachek A; Muntyanu A; Lee KA; Ye JY; Chandran V; Cook RJ; Gladman DD
Semin Arthritis Rheum; 2021 Feb; 51(1):144-149. PubMed ID: 33383290
[TBL] [Abstract][Full Text] [Related]
18. Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study.
Exarchou S; Di Giuseppe D; Klingberg E; Sigurdardottir V; Wedrén S; Lindström U; Turesson C; Jacobsson LTH; Askling J; Wallman JK
Ann Rheum Dis; 2024 Mar; 83(4):446-456. PubMed ID: 38049985
[TBL] [Abstract][Full Text] [Related]
19. Health related selection and death rates in the United Kingdom Atomic Energy Authority workforce.
Carpenter L; Beral V; Fraser P; Booth M
Br J Ind Med; 1990 Apr; 47(4):248-58. PubMed ID: 2337533
[TBL] [Abstract][Full Text] [Related]
20. The Risk of Mortality among Psoriatic Patients with Varying Severity: A Nationwide Population-Based Cohort Study in Taiwan.
Dai YX; Hsu MC; Hu HY; Chang YT; Chen TJ; Li CP; Wu CY
Int J Environ Res Public Health; 2018 Nov; 15(12):. PubMed ID: 30467301
[No Abstract] [Full Text] [Related]
[Next] [New Search]
